Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 17, 2023 20:56 UTC |
Wulf John WilliamDirector
|
Exercise / conversionCommon Stock | 80,000 | $4.50 | $360,000.00 |
DisclosureSEC source: 0001209191-23-019726 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · derivative · entry 10 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 70,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · derivative · entry 9 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,306 Underlying: Common Stock · 70,000 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on December 30, 2016, and became fully vested as of January 12, 2021. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 25,000 | $23.80 | $595,075.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,625 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.52 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 35,000 | $23.81 | $833,231.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,625 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.50 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 25,000 | $1.00 | $25,000.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 70,000 | $1.00 | $70,000.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 100,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-23-019723 · doc4.xml · derivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 100,000 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 55,000 | $23.81 | $1,309,423.50 |
DisclosureSEC source: 0001209191-23-019723 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,426 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.465 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 100,000 | $4.49 | $449,000.00 |
DisclosureSEC source: 0001209191-23-019723 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:44 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017545 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,188 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:44 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $24.44 | $197,820.60 |
DisclosureSEC source: 0001209191-23-017545 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.30 to $24.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 21:44 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $8.99 | $72,765.06 |
DisclosureSEC source: 0001209191-23-017545 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:44 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017545 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,282 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:44 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $24.36 | $197,197.36 |
DisclosureSEC source: 0001209191-23-017545 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.26 to $24.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:44 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $8.99 | $72,765.06 |
DisclosureSEC source: 0001209191-23-017545 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:20 UTC |
MCKENZIE DIANADirector
|
GrantOptions (Rights to Buy) · Derivative | 11,104 | $0.00 Strike: $22.79 | $0.00 |
DisclosureSEC source: 0001209191-23-011763 · doc4.xml · derivative · entry 2 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,104 Underlying: Common Stock · 11,104 shares Expires 2033-02-17 F2 · derivative.exercise_date: Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director. F2 · derivative.expiration_date: Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:20 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011763 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078 F1 · shares: Restricted stock units that vest in full on February 17, 2024, subject to continued service as a director. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 28,555 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · derivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,851 Underlying: Common Stock · 28,555 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 28,555 | $23.37 | $667,341.77 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.79 to $23.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 28,555 | $1.00 | $28,555.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:37 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-010204 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,376 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:37 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $22.98 | $186,027.64 |
DisclosureSEC source: 0001209191-23-010204 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.89 to $23.125, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:37 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $8.99 | $72,765.06 |
DisclosureSEC source: 0001209191-23-010204 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 19,594 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · derivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,406 Underlying: Common Stock · 19,594 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 30,406 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,406 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 50,000 | $22.98 | $1,149,060.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.59 to $23.225, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 19,594 | $1.00 | $19,594.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 30,406 | $3.00 | $91,218.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:37 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 25,881 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-010204 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,470 Underlying: Common Stock · 25,881 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:37 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 25,881 | $22.99 | $594,877.37 |
DisclosureSEC source: 0001209191-23-010204 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.66 to $23.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:37 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 25,881 | $8.99 | $232,670.19 |
DisclosureSEC source: 0001209191-23-010204 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:09 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 30,782 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-006787 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,351 Underlying: Common Stock · 30,782 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:09 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 30,782 | $22.99 | $707,561.21 |
DisclosureSEC source: 0001209191-23-006787 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.71 to $23.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:09 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 30,782 | $8.99 | $276,730.18 |
DisclosureSEC source: 0001209191-23-006787 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:09 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-006787 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,133 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:09 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $21.76 | $117,419.66 |
DisclosureSEC source: 0001209191-23-006787 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.53 to $21.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:09 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $8.99 | $48,510.04 |
DisclosureSEC source: 0001209191-23-006787 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 20, 2023 Filed Jan 23, 2023 21:06 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-004406 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,529 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| January 20, 2023 Filed Jan 23, 2023 21:06 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $19.92 | $107,495.87 |
DisclosureSEC source: 0001209191-23-004406 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.86 to $19.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 20, 2023 Filed Jan 23, 2023 21:06 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $8.99 | $48,510.04 |
DisclosureSEC source: 0001209191-23-004406 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:06 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 10,792 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-004406 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,925 Underlying: Common Stock · 10,792 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:06 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 10,792 | $19.73 | $212,943.43 |
DisclosureSEC source: 0001209191-23-004406 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.50 to $19.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:06 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 10,792 | $8.99 | $97,020.08 |
DisclosureSEC source: 0001209191-23-004406 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:28 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 20,723 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,406 Underlying: Common Stock · 20,723 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:28 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 20,723 | $19.78 | $409,888.51 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.65 to $20.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:28 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 20,723 | $3.00 | $62,169.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:28 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 25,722 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,129 Underlying: Common Stock · 25,722 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:28 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 25,722 | $19.91 | $512,225.34 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.59 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:28 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 25,722 | $3.00 | $77,166.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.